You're invited

To join Austrade and expert guests for lunch and a discussion of the Australian early-stage clinical trial advantage

Date & Time

Thursday, October 12th
12pm - 1.30pm (PDT)

Location

Chandlery at the Shore,
1200 Sierra Point Pkwy Suite 100A
Brisbane, CA 94005

Odette Hampton

Odette Hampton

Austrade

Read more

Odette Hampton

Odette Hampton

Austrade

Odette Hampton is Australia's Consul General and Senior Trade and Investment Commissioner for Austrade based in San Francisco.

Odette is an effective executive with more than a decade of experience working with globally scaling startups, providing commercial advice on their go to market strategy across the US, UK and Australia.

Prior to Austrade, Odette was the Head of Financial Services (ANZ) for the UK Department for International Trade (DIT) where she led the creation and implementation of the Australia-UK Fintech Bridge, contributed to trade policy and the Australia-UK Free Trade Agreement and advised British companies on global expansion following the Brexit referendum. Odette practiced as a lawyer at Gilbert + Tobin Perth, in the corporate advisory team.

Odette holds a Bachelor of Laws (Honours)/Bachelor of Arts from the University of Notre Dame Australia and studied abroad at The Catholic University of America in Washington DC where she interned in the US Senate. Odette has a Graduate Diploma of Legal Practice from the College of Law and has been admitted to practice in the Supreme Court of Western Australia.

Angela Luttick

Angela Luttick

360biolabs

Read more

Angela Luttick

Angela Luttick

360biolabs

Angela Luttick is Executive Vice President, Commercial at 360biolabs, a BioAgilytix company.

Co-founder and Executive Director, Angela leads business development and future expansion activities for 360biolabs. Angela has extensive drug discovery pharmaceutical experience and expertise in early phase drug discovery through to IND filing. With a background in virology and the combination of technical expertise and business acumen, Angela understands a client's requirements from the initial engagement.

Stewart Walker

Stewart Walker

Nucleus Network

Read more

Stewart Walker

Stewart Walker

Nucleus Network

Stewart Walker is based in San Francisco, and he has worked with US biotech companies exploring the benefits of doing clinical trials in Australia for over 7 years.

James Dietrich

James Dietrich

Acclime

Read more

James Dietrich

James Dietrich

Acclime

James is Head of Business Development UK & Europe for Acclime following 10+ years working in International Business Development. Across his career James has worked in multiple sectors including FinTech, Sports Marketing and Recruitment. With a focus on International Business Development, James has great knowledge in helping businesses navigate international expansion.

James joined Acclime to help it continue its rapid growth in helping UK & European businesses access the APAC region. With over 8000 clients globally, Acclime has established itself as a global leader in international professional services.

During his time at Acclime, James has worked extensively within the Life Science sector attending global industry events and speaking to the benefits of the Australian R&D incentive.

Arvinder Dhalla

Arvinder Dhalla

Guest Speaker

Read more

Arvinder Dhalla

Arvinder Dhalla

Guest Speaker

Dr. Arvinder Dhalla is Vice President of Clinical Development for Rani Therapeutics.

Dr. Dhalla joined Rani Therapeutics in 2016 with more than 15 years of experience in pharmaceutical research & development, project management and regulatory submissions across several therapeutic areas including, cardiovascular, metabolic diseases and PAH. Previously, Arvinder was Director of Biology in the Cardiovascular Therapeutic Area at Gilead Sciences from 2009-2015 where she led multiple drug development programs from early discovery to clinical development. Arvinder led several programs as a scientist and senior scientist from 2001-2008 at CV Therapeutics which was acquired by Gilead Sciences.

Dr. Dhalla holds several patents and has authored 50 scientific papers. Arvinder hold a BS and MS in Biophysics from Panjab University, India and a PhD in Physiology from University of Manitoba, Canada.

Emma Aitken

Emma Aitken

Austrade

Read more

Emma Aitken

Emma Aitken

Austrade

Emma Aitken is an Investment Director for Austrade, the Australian Government’s dedicated trade and investment agency.

Emma is focussed on life sciences and international health sectors, supporting US companies with their growth and expansion plans in Australia.

Prior to Austrade, Emma was a consultant with Melbourne market research firm, BDA. Emma holds Bachelor of Commerce (Finance), Bachelor of Science (Chemistry) and a Master of Science in Chemistry from Victoria University of Wellington, New Zealand. In her spare time, Emma serves as Treasurer for non-profit organization, Women in Science Portland.

Back to Event selection

Thank you for your interest. This event is now closed.